Vifor, which markets avacopan in the UK, has issued a safety communication, in agreement with the MHRA, advising that no new patients should be started on the medicine while the MHRA review is ongoing. Interim guidance pending the MHRA review Services and clinicians are asked to adopt the following...
Read more
Latest kidney centre data now available through UKRR portals
The UK Renal Registry (UKRR) has updated its Centre Summaries and Audit Standards portals with the latest verified kidney replacement therapy (KRT) data. Used by kidney teams across the UK, these interactive tools provide centre-level data to support local audit, benchmarking and quality improvement...
Read more
New Health Secretary urged to prioritise kidney disease
The appointment of a new Secretary of State for Health and Social Care marks the next opportunity to make the case for a Kidney Disease Modern Service Framework. Today, the kidney community has written to ensure kidney disease remains firmly on the Government's agenda. The UK Kidney Association has...
Read more
Loading content ...
Loading content ...